Alumis ALMS
NASDAQ ALMS
$6.81 +0.11 (+1.64%)
As of: Oct 21, 2026 · 2:16 PM EDT

Alumis (ALMS) Net Margin (2025 - 2026)

Updated

Alumis (ALMS) reported Net Margin of -8557.22% for Q2 2026, down 10782.31 percentage points from 2225.09% a year earlier.

Analysis

Alumis (ALMS) Net Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Alumis' Net Margin came in at -3443.77%; for FY2025, it was -1011.75%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,134.06 Bn 1,102.65 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 21.86%
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn 21.27%
4 Merck 367.24 Bn 321.62 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.48 Bn 235.17 Bn 12.86 Bn 16.30%
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn -134.51%
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -1.65%
10 Alumis 869.63 Mn -805.21 Mn - -8,557.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,557.22%
Dec 31, 2025 -4,817.26%
Sep 30, 2025 -5,363.02%
Jun 30, 2025 2,225.09%
Mar 31, 2025 -568.75%
API Access

Alumis Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY